logo
LiftmyCV Adds a Real-Time AI Cover Letter Generator to Supercharge Its Auto-Apply Agent

LiftmyCV Adds a Real-Time AI Cover Letter Generator to Supercharge Its Auto-Apply Agent

Built by job seekers, for job seekers — LiftmyCV delivers human-like, personalized cover letters for every application, without the burnout.
London, UK - May 30th, 2025 - LiftmyCV, the startup redefining how professionals apply for jobs, has launched a new feature that tackles one of the most frustrating parts of job hunting: writing cover letters.
The new AI Cover Letter Generator per Job creates personalized, context-aware cover letters for each role a user applies to — in real time, with a single click. It's designed to help applicants stand out in crowded inboxes, without spending hours rewriting the same intro lines over and over.
'Cover letters have always been a painful chore,' said Dan Zaitsev, founder of LiftmyCV. 'Most job seekers either skip them or send the same generic version to every company. We wanted to build a tool that makes every cover letter feel personal — without the work.'
A Problem Most Job Platforms Ignore
While resumes have become easier to generate with templates and AI tools, cover letters remain a pain point. Research shows that nearly 60% of hiring managers still expect them, yet most candidates either copy-paste generic versions or skip them entirely.
LiftmyCV's AI Cover Letter Generator uses the latest ChatGPT models to write original, role-specific letters — tailored to each job description and aligned with the user's profile. The letters are editable, professionally worded, and optimized to pass ATS filters, giving job seekers a better shot at interviews without sacrificing time or authenticity.
A Mission-Driven Approach to Modern Job Hunting
LiftmyCV was founded by a team of product builders and engineers who were tired of the inefficiencies of modern job platforms. The company is building a next-generation job search agent that doesn't just automate tasks — it enhances the application process with meaningful, personalized content.
From its auto-apply AI agent to its resume-to-profile converter and now smart cover letter generation, LiftmyCV is evolving into a full-stack job search platform designed to help professionals apply faster, smarter, and without burnout.
'The job search process is broken,' Zaitsev adds. 'We're building tools that treat job seekers like real people, not just clicks in a funnel.'
How It Works
After uploading their resume and completing a job seeker profile, users simply activate the AI Cover Letter Generator when applying to a job through LiftmyCV's platform. The tool analyzes the job description, matches it with the user's profile, and writes a unique, high-quality cover letter tailored to that specific opportunity.
Each letter is:
Combined with LiftmyCV's AI job search agent, which auto-applies to roles across LinkedIn, Workable, Lever, and more, this new feature turns the traditionally exhausting job hunt into a smoother, more strategic process.
About LiftmyCV
LiftmyCV is a modern job search platform that uses AI to automate and improve how professionals apply for jobs. With features like auto-apply agents, ATS-ready resumes, and personalized cover letters, LiftmyCV helps users navigate the job market more efficiently — without compromising quality. The team operates remotely and is committed to building a more human-centered job search experience.
Try the AI Cover Letter Generator here: https://www.liftmycv.com/ai-cover-letter-generator/
Media Contact
Company Name: VENTURE HEADS LLP
Contact Person: PR department
Email: Send Email
Country: United Kingdom
Website: https://www.liftmycv.com/
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: LiftmyCV Adds a Real-Time AI Cover Letter Generator to Supercharge Its Auto-Apply Agent
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hilton's to open Curio Collection hotel in UK in 2026
Hilton's to open Curio Collection hotel in UK in 2026

Yahoo

time28 minutes ago

  • Yahoo

Hilton's to open Curio Collection hotel in UK in 2026

Hilton is continuing the expansion of its Curio Collection hotel brand in the UK with the signing of the Derby London City, which is set to open in early 2026. This development, signed under a franchise agreement with real estate developer and operator Dominus, marks the brand's tenth property in the UK. It also reflects Hilton's growing luxury and lifestyle portfolio, which recently celebrated its 1,000th hotel launch worldwide. Hilton UK, Ireland and the Nordics development vice-president Nick Smart said: 'Curio Collection by Hilton's continued expansion in the UK is a testament to the popularity and commercial success of our forward-thinking lifestyle brand.' The hotel will be owned by Dominus and managed under its Dominus Hospitality platform. The project involves transitioning a previous office space on Great Tower Street into the latest hospitality venture. Located in London's financial district, the Square Mile, the Derby London City aims to serve the needs of business travellers with 237 guest rooms, including ten suites. The property will offer an all-day dining restaurant, a 24-hour gym, meeting rooms, and private dining facilities. Dominus CEO Preet Ahluwalia said: 'As owners and operators of Lost Property St Paul's, we knew we could leverage our expertise, in partnership with Hilton, to deliver another Curio Collection hotel in a prime location. 'Since we acquired the site on Great Tower Street in 2023, we've taken a sustainable design approach to refurbishing and upgrading the existing building, to create a hotel that pays tribute to the past and offers an exceptional guest experience in the heart of London.' The property is set to support the City of London Corporation's Destination City programme, which aims to promote the Square Mile as a location for both business and leisure. City of London Corporation Planning and Transportation Committee chairman Tom Sleigh said: 'The City of London's new hotel stock will play a major role in realising the 'Destination City' growth strategy, by helping to accommodate the rapidly rising numbers of visitors and workers coming to the Square Mile, every day.' The Derby London City becomes part of Dominus's existing hotel portfolio, which encompasses properties such as Lost Property St Paul's London, Curio Collection by Hilton, and Hampton by Hilton Bath City. Last month, Hilton continued its expansion by unveiling The Marcus Portrush, a Tapestry Collection hotel, marking the brand's entrance into Northern Ireland, UK. "Hilton's to open Curio Collection hotel in UK in 2026" was originally created and published by Hotel Management Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

KFC to open 50 new stores across UK in 2025
KFC to open 50 new stores across UK in 2025

Yahoo

time28 minutes ago

  • Yahoo

KFC to open 50 new stores across UK in 2025

Fast food giant KFC has unveiled plans to establish more than 50 new dining locations across the UK in 2025, forming a key part of a £1.5bn ($2.04bn) investment to expand its presence in the UK and Ireland (UK&I). Currently operating 1,000 restaurants nationwide, KFC has set a target to open 500 additional venues by 2034. BDC Magazine reports that the restaurant company has pledged £466m up to 2030 to drive this expansion, while also committing to revamp more than 200 existing sites to upgrade facilities and improve customer satisfaction. To achieve this growth, KFC is searching for both freehold and leasehold properties, focusing on sites in retail parks, leisure complexes, high streets, transport hubs, shopping centres and food courts. The chain is particularly interested in drive-through locations ranging from 0.3 to 1.5 acres and in-line units spanning between 1,200ft² and 2,500ft². The expansion will cover all regions of the UK and Ireland, with a strong emphasis on accessibility and prominence. To encourage property experts to identify suitable locations, KFC is offering a £20,000 finder's fee for successful site recommendations. The initiative highlights KFC's confidence in the UK and Irish markets and its dedication to long-term development. In November 2023, KFC UK&I collaborated with Uber Direct to facilitate fast order deliveries to its customers in the region. Orders placed by the customers via the KFC app will use the same tech and courier network that powers Uber Eats. "KFC to open 50 new stores across UK in 2025" was originally created and published by Verdict Food Service, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report
Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report

Yahoo

time39 minutes ago

  • Yahoo

Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Novo Nordisk A/S' (NYSE:NVO) executives allegedly ignored internal warnings that the company was unprepared to launch its obesity drug Wegovy. As rival Eli Lilly and Co.'s (NYSE:LLY) Zepbound gains momentum, the Danish pharmaceutical giant is grappling with the fallout of those early decisions. Wegovy, approved in the U.S. in mid-2021, marked a major advancement in obesity treatment and helped Novo generate $46 billion in net profit since then. Trending: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — But the company has struggled to keep pace with Lilly's Zepbound, which has surpassed Wegovy in weekly new prescriptions this year. Amid concerns over its competitiveness in the weight-loss market, Novo is undergoing a leadership shake-up, including the recent dismissal of CEO Lars Fruergaard Jorgensen and earlier departures like U.S. chief Doug Langa. Sources told Reuters that during tense internal meetings, sales and marketing staff warned Langa about launching Wegovy too quickly after FDA approval. They urged a delay until supply and insurance coverage were more secure. With a list price of up to $1,300 per month, many patients found the drug unaffordable without insurance, and Novo missed an opportunity to build a more stable launch pad while Lilly's market entry was still years company leadership in Copenhagen held to conservative sales expectations through 2025, Reuters report highlighted, underestimating the scale of demand driven by the global obesity epidemic. Former employees said Novo had internal indicators pointing to stronger uptake but failed to adjust its strategy accordingly. The consequences were swift. Wegovy's launch was plagued by supply shortages, leaving patients without doses and discouraging new users. The high cost also pushed some patients toward the gray market of compounded drugs. Novo further faced criticism for pricing Wegovy significantly higher than its diabetes drug Ozempic, while Lilly entered the market with Zepbound at $1,080 and provided steep discounts through its LillyDirect pharmacy. One former insider claimed that Novo hesitated to offer competitive rebates to pharmacy benefit managers (PBMs), limiting the drug's accessibility. This reluctance hurt relationships with insurers and failed to secure broader coverage, placing Novo at a disadvantage compared to Lilly's aggressive pricing and reimbursement strategies. Recently, Novo Nordisk launched its weight-loss drug Wegovy (semaglutide) in India to compete with Eli Lilly. Read Next: $100k+ in investable assets? Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes – no cost, no obligation. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo by Tobias Arhelger via Shutterstock This article Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store